Fudan University: all 1,308 studies

Page 12 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.

• Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast CancerCompletedNCT02687490Phase 2
• Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT02677597Phase 3
• Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast CancerStatus unknownNCT02670668Not applicable
• Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell CarcinomasStatus unknownNCT02665702Phase 2
• Irinotecan as 3rd Line Therapy in Gastric CancerStatus unknownNCT02662959Phase 2
• A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCCCompletedNCT02647125Phase 2
• TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA SignatureActive, not recruitingNCT02641847Phase 2/3
• Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial TumorsCompletedNCT02636556Not applicable
• Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic CancerStatus unknownNCT02635971Phase 2
• Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver MetastasisStatus unknownNCT02634502Phase 2
• Adjuvant Treatment for Incomplete Resection Thymoma or Thymic CarcinomaWithdrawnNCT02633514Phase 3
• Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver MetastasisStatus unknownNCT02631564
• Efficacy Study of TACE to Treat Hepatocellular Carcinoma After OperationStatus unknownNCT02631499Phase 4
• Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 VariationsCompletedNCT02628613Phase 2
• Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal CancerStatus unknownNCT02618356Phase 2
• Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving SurgeryStatus unknownNCT02617082
• Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving SurgeryStatus unknownNCT02617043Phase 2
• Axillary Radiotherapy for Early Stage Breast Cancer With Limited Positive Sentinel Lymph NodesStatus unknownNCT02612012
• Platinum Rechallenge in Patients With Platinum-sensitive mTNBCStatus unknownNCT02607215Phase 2
• Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1CompletedNCT02605265Phase 3
• Analgesia Effects of Nalbuphine vs SulfentanilStatus unknownNCT02604797Not applicable
• Incision Pain and Uterine Contraction Pain After Cesarean SectionStatus unknownNCT02595333Not applicable
• A Prospective Clinical Study for Transanal Double Purse-string Rectal Anastomosis Preformed With KOL StaplerStatus unknownNCT02565667Not applicable
• The Effective Effect-Site Propofol Concentration for Induction and Intubation for Schnider Model in ParturientsStatus unknownNCT02554175Not applicable
• ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)CompletedNCT02546934Phase 3
• Heating Precondition of Streamlined Liner of the Pharynx Airway Decrease the Incidence of Sore ThroatStatus unknownNCT02539485Not applicable
• Heating Precondition of Epidural Catheter Decrease the Incidence of Injury to Blood Vessel During Epidural Catheter PlacementStatus unknownNCT02537665Not applicable
• Detecting Hypotension By Continuous Non-invasive Arterial Pressure MonitoringStatus unknownNCT02532270Not applicable
• Laparoscopic Versus Open Liver Resection for Hepatocellular CarcinomaStatus unknownNCT02526043Not applicable
• Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of PancreasStatus unknownNCT02514928Phase 3
• Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative ResectionStatus unknownNCT02506842Phase 3
• Effect of Sufentanil and RopivacaineCompletedNCT02488291Not applicable
• A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal CancerCompletedNCT02459457Phase 3
• Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer PatientsStatus unknownNCT02415829Phase 2
• The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric CancerCompletedNCT02395640Phase 3
• Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell CarcinomaStatus unknownNCT02384811Phase 2
• Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer PatientsStatus unknownNCT02376452Phase 2
• Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) PatientsTerminatedNCT02348281Phase 2
• Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC)Status unknownNCT02341911Phase 2
• Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed EmesisCompletedNCT02336750Phase 3
• Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 DiabetesCompletedNCT02303730Phase 4
• Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised TrialCompletedNCT02298062Phase 3
• A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer PatientsStatus unknownNCT02291744Phase 2
• National Study on Autism Spectrum Disorder in ChinaCompletedNCT02200679
• Effect of Laparoscopic Operation on Rocuronium and Cisatracurium: Pharmacokinetic and Pharmacodynamic AnalysisCompletedNCT02194855Phase 4
• Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABCWithdrawnNCT02140437Phase 2
• A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast CancerCompletedNCT02137083Phase 2
• Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial InfarctionCompletedNCT02131220Phase 4
• Role of Barrier Resection in Local Control for Extremity Recurrent Soft Tissue SarcomasStatus unknownNCT02120768Phase 3
• Left Celiac Plexus Resection for Pancreatic Cancer at the Body and TailStatus unknownNCT02117895Phase 3
• The Effect of Modified Valsalva Maneuver on Filling Degree of Internal Jugular VeinCompletedNCT02095002
• Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric CancerStatus unknownNCT02072317Phase 2
• Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC PatientsStatus unknownNCT02039518Phase 2
• Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLCStatus unknownNCT02037997Phase 2
• Effect of Dexmedetomidine on Bispectral Index and Propofol Requirements During Different Menstrual CycleCompletedNCT02035930Phase 4
• Treatment of Cerebral Radiation Necrosis (CRN) With Nerve Growth Factor (NGF)CompletedNCT02032147
• Observational Study of Dydrogesterone in Cycle RegularizationCompletedNCT02029144
• Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric CarcinomaStatus unknownNCT02024217Phase 2
• Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPCCompletedNCT02012062Phase 3
• A Trial of Robotic-assisted Versus Laparoscopic Abdominoperineal Resection for Treating Low Rectal CancerCompletedNCT01985698Not applicable
• The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology PatientsCompletedNCT01968525Not applicable
• A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGCStatus unknownNCT01963702Phase 2
• Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical SurgeryStatus unknownNCT01936233Phase 3
• Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerStatus unknownNCT01924078Phase 2
• Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHLStatus unknownNCT01914744Phase 2
• Dose-adjusted EPOCH-R in MYC Positive DLBCLTerminatedNCT01914718Phase 2
• Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACEStatus unknownNCT01895010Phase 2
• Treatment of Cerebral Radiation Necrosis With GM1, a Prospective StudyStatus unknownNCT01884987
• Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF）Status unknownNCT01881516Phase 2
• A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive BiomarkersStatus unknownNCT01860508Not applicable
• S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical StudyCompletedNCT01854749Phase 2
• Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal CancerStatus unknownNCT01843049Phase 1/2
• Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC (ECTOP-1001)CompletedNCT01833572Phase 2
• Study of S-1 in Combination With Radiotherapy in Esophageal CancerCompletedNCT01831531Phase 2
• Relationship Between Hypoxia and Endocrine Response in Human Breast CancerStatus unknownNCT01814449
• ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLCCompletedNCT01810367Phase 2
• Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)CompletedNCT01807936Not applicable
• Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCLStatus unknownNCT01804127Phase 2
• The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung CancerCompletedNCT01797913Phase 2
• QYHJ Granules Versus Xeloda in Metastatic Pancreatic CancerStatus unknownNCT01796782Phase 2
• Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLCCompletedNCT01769066Phase 2/3
• Preconceptional Thyroid Screening and Childhood Nerocognitive FunctionStatus unknownNCT01744743Not applicable
• wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer PatientsStatus unknownNCT01736904Phase 2
• Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After PancreaticoduodenectomyCompletedNCT01731821Phase 3
• Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPaseStatus unknownNCT01715532Phase 2
• Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast CancerCompletedNCT01712893Phase 3
• Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total GastrectomyStatus unknownNCT01697943Phase 3
• Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric JunctionStatus unknownNCT01697917Phase 3
• The Optimal Width of Gastric Conduit for Minimally Invasive Esophagectomy: Wide or Narrow?Status unknownNCT01696682Not applicable
• Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)CompletedNCT01687439Phase 2
• Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 ExpressionStatus unknownNCT01681446Phase 3
• The Clinical Trail Of NAFLD Treated By Traditional Chinese MedicineCompletedNCT01677325Phase 1
• Detection and Enumeration of Circulating Tumor Cells in Rectal CancerStatus unknownNCT01671891
• Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell LymphomaStatus unknownNCT01667302Phase 2
• Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell LymphomaTerminatedNCT01667289Phase 2
• Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) PatientsCompletedNCT01658033Phase 2
• A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)TerminatedNCT01655992Phase 3
• A Study of Famitinib Malate in HER2-negative Metastatic Breast CancerCompletedNCT01653574Phase 2
• A Study of Apatinib in Non-triple-negative Metastatic Breast CancerCompletedNCT01653561Phase 2
• Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal CancerStatus unknownNCT01614938Phase 2

← Fudan University overview and focus areas